Evidence map›Paper›PMID 32030599›Full record

ArticleMolecular biology reports2020

Neuroprotective effect of rutin against colistin-induced oxidative stress, inflammation and apoptosis in rat brain associated with the CREB/BDNF expressions.

Hamit Çelik, Fatih Mehmet Kandemir, Cuneyt Caglayan, Selçuk Özdemir, Selim Çomaklı, Sefa Kucukler, Ahmet Yardım

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Evaluation of the Influence ofMolecules (Basel, Switzerland) · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hamit ÇelikDepartment of Neurology, Private Buhara Hospital, Erzurum, Turkey.
Fatih Mehmet KandemirDepartment of Biochemistry, Faculty of Veterinary Medicine, Atatürk University, 25240, Erzurum, Turkey. fkandemir03@gmail.com.ORCID http://orcid.org/0000-0002-8490-2479
Cuneyt CaglayanDepartment of Biochemistry, Faculty of Veterinary Medicine, Bingol University, 12000, Bingol, Turkey. ccaglayan@bingol.edu.tr.
Selçuk ÖzdemirDepartment of Genetics, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Selim ÇomaklıDepartment of Pathology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Sefa KucuklerDepartment of Biochemistry, Faculty of Veterinary Medicine, Atatürk University, 25240, Erzurum, Turkey.
Ahmet YardımDepartment of Neurosurgery, Private Buhara Hospital, Erzurum, Turkey.
Atatürk University · TRErzurum Regional Training and Research Hospital · TRBingöl University · TR

Funding

Erzurum Private Buhara Hospital .
6 · The paper itself

Abstract

The purpose of the current study was to examine the neuroprotective effect of rutin against colistin-induced neurotoxicity in rats. Thirty-five male Sprague Dawley rats were randomly divided into 5 groups. The control group (orally received physiological saline), the rutin group (orally administered 100 mg/kg body weight), the colistin group (i.p. administered 15 mg/kg body weight), the Col + Rut 50 group (i.p. administered 15 mg/kg body weight of colistin, and orally received 50 mg/kg body weight of rutin), the Col + Rut 100 group (i.p. administered 15 mg/kg body weight of colistin, and orally received 100 mg/kg body weight of rutin). Administration of colistin increased levels of glial fibrillary acidic protein and brain-derived neurotrophic factor and acetylcholinesterase and butyrylcholinesterase activities while decreasing level of cyclic AMP response element binding protein and extracellular signal regulated kinases 1 and 2 (ERK1/2) expressions. Colistin increased oxidative impairments as evidenced by a decrease in level of nuclear factor erythroid 2-related factor 2 (Nrf-2), glutathione, superoxide dismutase, glutathione peroxidase and catalase activities, and increased malondialdehyde content. Colistin also increased the levels of the apoptotic and inflammatoric parameters such as cysteine aspartate specific protease-3 (caspase-3), p53, B-cell lymphoma-2 (Bcl-2), nuclear factor kappa B (NF-κB), Bcl-2 associated X protein (Bax), tumor necrosis factor-α (TNF-α) and neuronal nitric oxide synthase (nNOS). Rutin treatment restored the brain function by attenuating colistin-induced oxidative stress, apoptosis, inflammation, histopathological and immunohistochemical alteration suggesting that rutin supplementation mitigated colistin-induced neurotoxicity in male rats.

Indexed as

AnimalsApoptosisBiomarkersBrainBrain-Derived Neurotrophic FactorColistinCyclic AMP Response Element-Binding ProteinImmunohistochemistryInflammationMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Neuroprotective AgentsOxidative StressRatsRutinBDNF protein, humanBiomarkersBrain-Derived Neurotrophic FactorColistinCREB1 protein, humanCyclic AMP Response Element-Binding ProteinMAPK1 protein, humanMAPK3 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Neuroprotective AgentsRutinApoptosisColistinInflammationNeurotoxicityOxidative stressRutin

Identifiers

PMID32030599
OpenAlexW3004610667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.